| DRUG WATCH |
|
| Year : 2013 | Volume
: 45
| Issue : 3 | Page : 305-306 |
A case of rhabdomyolysis complicated with acute renal failure after resumption of fenofibrate therapy: A first report
Muharrem Kiskac1, Mehmet Zorlu1, Mustafa Cakirca1, Cumali Karatoprak1, Celalettin Peru1, Reha Erkoc1, Erdinc Yavuz2
1 Faculty of Medicine, Internal Medicine Clinic, Bezmialem Vakif University, 34093 Fatih, Istanbul, Turkey
2 Faculty of Medicine, Family Medicine Clinic, Recep Tayyip Erdogan University, 53100 Rize, Turkey
Correspondence Address:
Muharrem Kiskac
Faculty of Medicine, Internal Medicine Clinic, Bezmialem Vakif University, 34093 Fatih, Istanbul
Turkey
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0253-7613.111912
Adverse effects due to use of fibrates often relate to the skeletal muscle, kidneys, or liver. Rhabdomyolysis is a most serious potential adverse effect. We present a case of resumed fenofibrate induced rhabdomyolysis complicated with acute renal failure.
[FULL TEXT] [PDF]*
|
